首页> 外文期刊>Journal of Pharmaceutical Analysis >Analytical quality-by-design approach for sample treatment of BSA-containing solutions
【24h】

Analytical quality-by-design approach for sample treatment of BSA-containing solutions

机译:设计质量分析方法用于样品处理含BSA的溶液

获取原文
           

摘要

The sample preparation of samples containing bovine serum albumin (BSA), e.g., as used in transdermal Franz diffusion cell (FDC) solutions, was evaluated using an analytical quality-by-design (QbD) approach. Traditional precipitation of BSA by adding an equal volume of organic solvent, often successfully used with conventional HPLC-PDA, was found insufficiently robust when novel fused-core HPLC and/or UPLC-MS methods were used. In this study, three factors (acetonitrile (%), formic acid (%) and boiling time (min)) were included in the experimental design to determine an optimal and more suitable sample treatment of BSA-containing FDC solutions. Using a QbD and Derringer desirability ( D ) approach, combining BSA loss, dilution factor and variability, we constructed an optimal working space with the edge of failure defined as D <0.9. The design space is modelled and is confirmed to have an ACN range of 83±3% and FA content of 1±0.25%.
机译:使用按设计分析质量(QbD)方法评估含牛血清白蛋白(BSA)的样品的样品制备,例如用于透皮Franz扩散池(FDC)溶液的样品。当使用新型的熔融核芯HPLC和/或UPLC-MS方法时,发现通常通过与常规HPLC-PDA一起成功使用的等体积有机溶剂来沉淀BSA的传统方法不够牢固。在这项研究中,实验设计中包括三个因素(乙腈(%),甲酸(%)和沸腾时间(分钟)),以确定含BSA的FDC溶液的最佳且更合适的样品处理方法。使用QbD和Derringer期望值(D)方法,结合BSA损失,稀释因子和可变性,我们构建了故障边缘定义为D <0.9的最佳工作空间。对设计空间进行了建模,并确认其ACN范围为83±3%,FA含量为1±0.25%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号